CDK2-IN-11
CDK2-IN-11 (compound 9d) is a potent CDK2 inhibitor with an IC50 of 6.4 μM, and KI values of 23.4 nM, 56.3 nM and 44.3 nM for hCA II, hCA IX and hCA XII, respectively. CDK2-IN-11 can be used for researching anticancer[1].
Product Specifications
CAS Number
2410402-82-1
UNSPSC
12352005
Target
Carbonic Anhydrase; CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-11.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(/N=N/C2=C3N=CC=C(C4=CC=C(Cl)C=C4)N3N=C2N)C=C1)(N)=O
Molecular Formula
C18H14ClN7O2S
Molecular Weight
427.87
References & Citations
[1]Said MA, et al. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. Eur J Med Chem. 2020 Mar 1;189:112019.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CA II; CA IX; CA XII
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Hexakis[μ-(Acetato-κO:κO')]triaqua-μ3-oxotri-iridium(1+) Acetate](https://cdn.genprice.uk/products/572/6865042340152/imageurl/trc-i766015-25mg.webp)
TRC-I766015-25MG 25 mg
Hexakis[μ-(Acetato-κO:κO')]triaqua-μ3-oxotri-iridium(1+) Acetate
Sign In for Pricing
View Details 
